# LionBird

LionBird is a Private Equity based in Tel Aviv, Israel.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Tel Aviv, Israel
- **Region:** Middle East
- **Address:** Tel Aviv, Israel
- **Founded:** 2012
- **Assets under management:** Undisclosed
- **Website:** lionbird.com
- **LinkedIn:** https://www.linkedin.com/company/lionbird

## Regulatory record

- **CRD number:** 318797
- **SEC file number:** 802-132609
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/318797

## About

LionBird is an exempt reporting adviser, established in Tel Aviv in 2025. It has been registered since then.

## Sectors

- Digital Health
- Enterprise Software
- FinTech
- Cybersecurity

## Offices

- Chicago, IL, United States

## People

- Robert Schwartz — Managing Partner
- Chaim Schiff — Managing Partner

## Questions

### Who invests at LionBird — and what's the decision-making structure?

Managing Partners Robert Schwartz and Chaim Schiff lead investment decisions, drawing on their respective operator backgrounds and the broader investment team across Tel Aviv and Chicago. The firm runs a concentrated portfolio model, meaning each partner is directly involved in diligence and post-investment board work. No external investment committee governs their process.

### How does LionBird source deals across two countries?

The firm's Tel Aviv office captures early-stage Israeli startups, particularly in enterprise software, cybersecurity, and digital health. The Chicago office connects portfolio companies to US commercial partners, customers, and follow-on capital. This dual-presence model means LionBird can source technical founders locally while structuring a US-facing growth plan from day one.

### Is LionBird a generalist VC or sector-specific?

LionBird is thesis-driven within specific sectors: enterprise software, digital health, fintech, and cybersecurity. The firm does not invest in consumer apps, hardware, or pure-play biotech. This concentration reflects the technical strengths of Israeli founding teams and the go-to-market expertise of the Chicago partnership group.

## Related profiles

- [Linzor Capital Partners](https://altss.com/profile/linzor-capital-partners)
- [Lion Capital](https://altss.com/profile/lion-capital)

---

Last updated: 2026-08-14T12:30:00.000Z

Canonical page: https://altss.com/profile/lionbird

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology